Department of Veterinary Physiology, College of Veterinary Medicine, Biosafety Research Institute, Chonbuk National University, Jeonju 561-756, Korea.
J Ginseng Res. 2013 Jul;37(3):273-82. doi: 10.5142/jgr.2013.37.273.
The present study was designed to investigate the cardioprotective effects of Korean Red Ginseng extract (KRG) on isoproterenol (ISO)-induced cardiac injury in rats, particularly in regards to electrocardiographic changes, hemodynamics, cardiac function, serum cardiac enzymes, components of the myocardial antioxidant defense system, as well as inflammatory markers and histopathological changes in heart tissue. ISO (150 mg/kg, subcutaneous, two doses administered at 24-hour intervals) treatment induced significant decreases in P waves and QRS complexes (p<0.01), as well as a significant increase in ST segments. Moreover, ISO-treated rats exhibited decreases in left-ventricular systolic pressure, maximal rate of developed left ventricular pressure (+dP/dtmax) and minimal rate of developed left ventricular pressure (-dP/dtmax), in addition to significant increases in lactate dehydrogenase, aspartate transaminase, alanine transaminase and creatine kinase activity. Heart rate, however, was not significantly altered. And the activities of superoxide dismutase, catalase and glutathione peroxidase were decreased, whereas the activity of malondialdehyde was increased in the ISO-treated group. ISO-treated group also showed increased caspase-3 level, release of inflammatory markers and neutrophil infiltration in heart tissue. KRG pretreatment (250 and 500 mg/kg, respectively) significantly ameliorated almost all of the parameters of heart failure and myocardial injury induced by ISO. The protective effect of KRG on ISO-induced cardiac injury was further confirmed by histopathological study. In this regard, ISO treatment induced fewer morphological changes in rats pretreated with 250 or 500 mg/kg of KRG. Compared with the control group, all indexes in rats administered KRG (500 mg/kg) alone were unaltered (p>0.05). Our results suggest that KRG significantly protects against cardiac injury and ISO-induced cardiac infarction by bolstering antioxidant action in myocardial tissue.
本研究旨在探讨高丽红参提取物(KRG)对异丙肾上腺素(ISO)诱导的大鼠心脏损伤的心脏保护作用,特别是在心电图变化、血液动力学、心脏功能、血清心脏酶、心肌抗氧化防御系统成分以及心脏组织中的炎症标志物和组织病理学变化方面。ISO(150mg/kg,皮下,24 小时间隔两次给药)处理导致 P 波和 QRS 复合物显著降低(p<0.01),并且 ST 段显著升高。此外,ISO 处理的大鼠左心室收缩压、最大左心室压力发展速率(+dP/dtmax)和最小左心室压力发展速率(-dP/dtmax)降低,同时乳酸脱氢酶、天冬氨酸转氨酶、丙氨酸转氨酶和肌酸激酶活性显著增加。然而,心率没有显著改变。超氧化物歧化酶、过氧化氢酶和谷胱甘肽过氧化物酶的活性降低,而 ISO 处理组丙二醛的活性增加。ISO 处理组还显示心脏组织中 caspase-3 水平升高、炎症标志物释放和中性粒细胞浸润增加。KRG 预处理(分别为 250 和 500mg/kg)显著改善了 ISO 诱导的心力衰竭和心肌损伤的几乎所有参数。组织病理学研究进一步证实了 KRG 对 ISO 诱导的心脏损伤的保护作用。在这方面,ISO 处理在 250 或 500mg/kg KRG 预处理的大鼠中引起的形态变化较少。与对照组相比,单独给予 KRG(500mg/kg)的大鼠的所有指标均未改变(p>0.05)。我们的结果表明,KRG 通过增强心肌组织中的抗氧化作用,显著保护心脏免受 ISO 诱导的心脏损伤和梗塞。